Unknown

Dataset Information

0

Clofarabine?phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase?dependent apoptosis.


ABSTRACT: Clofarabine (2?chloro?2'?fluoro?2'?deoxyarabinosyladenine, CIF), a second?generation 2'?deoxyadenosine analog, possesses a variety of anti?cancer activities, including the capacity to modulate DNA methylation marks. Bioactive nutrients, including resveratrol (RSV) and all?trans retinoic acid (ATRA) have been indicated to regulate epigenetic machinery in malignant cells. The purpose of the current study was to evaluate whether the tested phytochemicals, RSV or ATRA, can improve the therapeutic epigenetic effects of CIF in chronic myeloid leukemia (CML) cells. The present study investigates, to the best of our knowledge, for the first time, the influence of CIF in combination with RSV or ATRA on the expression of relevant modifiers of DNA methylation machinery, including DNA Methyltransferase 1 (DNMT1) and Cyclin dependent kinase inhibitor 1A (CDKN1A) in CML cells. Subsequently, the combinatorial effects on promoter methylation and transcript levels of methylation?silenced tumor suppressor genes (TSGs), including phosphatase and tensin homologue (PTEN) and retinoic acid receptor beta (RARB), were estimated using MSRA and qPCR, respectively. The tested TSGs were chosen according to bioinformatical analysis of publicly available clinical data of human DNA methylation and gene expression arrays in leukemia patients. The K562 cell line was used as an experimental CML in vitro model. Following a period of 72 h exposure of K562 cells, the tested combinations led to significant cell growth inhibition and induction of caspase?3?dependent apoptosis. These observations were accompanied by DNMT1 downregulation and CDKN1A upregulation, with a concomitant enhanced decrease in DNMT1 protein level, especially after ATRA treatment with CIF. Concurrent methylation?mediated RARB and PTEN reactivation was detected. The results of the current study demonstrated that CIF that was used in combination with the tested phytochemicals, RSV or ATRA, exhibited a greater ability to remodel DNA methylation marks and promote cell death in CML cells. These results may support the application of CIF combinations with natural bioactive agents in anti?leukemic epigenetic therapy.

SUBMITTER: Kaufman-Szymczyk A 

PROVIDER: S-EPMC6755200 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis.

Kaufman-Szymczyk Agnieszka A   Majda Katarzyna K   Szuławska-Mroczek Agata A   Fabianowska-Majewska Krystyna K   Lubecka Katarzyna K  

Molecular medicine reports 20190827 4


Clofarabine (2‑chloro‑2'‑fluoro‑2'‑deoxyarabinosyladenine, CIF), a second‑generation 2'‑deoxyadenosine analog, possesses a variety of anti‑cancer activities, including the capacity to modulate DNA methylation marks. Bioactive nutrients, including resveratrol (RSV) and all‑trans retinoic acid (ATRA) have been indicated to regulate epigenetic machinery in malignant cells. The purpose of the current study was to evaluate whether the tested phytochemicals, RSV or ATRA, can improve the therapeutic ep  ...[more]

Similar Datasets

| S-EPMC9336537 | biostudies-literature
2013-12-30 | E-GEOD-41372 | biostudies-arrayexpress
| S-EPMC5289955 | biostudies-literature
2021-03-02 | GSE112481 | GEO
| S-EPMC2664004 | biostudies-literature
| S-EPMC3741511 | biostudies-other
| S-EPMC8052721 | biostudies-literature
| S-EPMC8424959 | biostudies-literature
| S-EPMC2719666 | biostudies-literature
2013-12-30 | GSE41372 | GEO